1. Junior Consultant, Dept. of Medicine, United Hospital Dhaka, 2. Professor (PRL), Dept. of Medicine, Dhaka Medical College, 3. Senior Medical Officer, EECP Heart Therapy, The Medical Centre, Dhaka, 4. Assistant Professor, Dept. of Medicine, Dhaka Medical College, 5. Student, FCPS Medicine P-II Course, Dhaka Medical College, 6 . Assistant Registrar, Dept. of Neurology, Dhaka Medical College Hospital, 7. Student, FCPS Medicine P-II Course, Dhaka Medical College, within six months if not treated with prophylactic â-blockers or endoscopic therapy. 2 Albumin (50%-60% of total plasma protein), globulin, and fibrinogen make up the major share of plasma proteins with 24%-56% increased risk of death per 2.5 g% fall in serum albumin. 3, 4 Child-Pugh score (serum albumin being integral part of the score) predicts advanced liver disease. 5 Liver produces albumin at a rate of 130-200 mg/kg/day. 3 Hypoalbuminemia in cirrhosis is multifactorial and may be due to reduced production (liver parenchyma replaced by fibrous tissue), increased removal by reticuloendothelial system (spleen) or increased loss through gut 6 (portal gastropathy/enteropathy): all related to portal hypertension. Hypoalbuminemia with associated ultrasonographic features e.g. gallbladder wall thickness 5 and right liver lobe diameter 7 have been cited as non-endoscopic predictors of esophageal varices. Similarly, Serum Ascitic Albumin Gradient (the difference between the serum and ascetic albumin concentration) i.e. SAAG, is thought to be an indirect marker of portal hypertension, 8 with a high gradient (>1.1 g/dL) indicating portal hypertension and presence of EV.
Portal hypertension (portal pressure >12 mm Hg or >5 mm Hg gradient between the wedged hepatic venous pressure and the free hepatic venous pressure has been shown in animal studies to induce hypoalbuminemia. 9 Conversely, serum albumin is increased by 20% when portal pressure is reduced after Trans jugular Intra-hepatic Porto-systemic Shunt Procedure suggesting a link between portal hypertension and hypoalbuminaemia.
Materials and Methods:
In this cross-sectional study, a total number of 100 randomly selected, clinically diagnosed patients of chronic liver disease were studied for a period of June 2010 to November 2010 (6 months) at medicine units and gastroenterology department of Dhaka Medical College Hospital. Clinically CLD diagnosed interlaying one or more stisgment or child. All patients were assessed as per Child-Pugh class and had full blood count, HBsAg, Anti-HCV antibodies by ELISA, abdominal ultrasound and Endoscopy of upper gastrointestinal tract. Exclusion criteria were patients receiving sclerotherapy, band ligation of EV and prophylactic treatment for portal hypertension, hypoalbuminemia which in clinically correlated with congenital cardiac failure nephritic syndrome or malnutrition patient refusing to give consent to take part in our study. This study was carried out to correlate between serum albumin and EV in CLD. Patients were divided into Group A (serum albumin <3.5 gm and Group B (albumin >3.5 g/day). Statistical analysis was carried out by using SPSS v16.0 Windows statistical software. Descriptive statistics were used for the interpretation of the findings. Informed and written consent obtained from all patients or their guardian. Formal Ethical Clearance was obtained from the Research Review Committee of Dhaka Medical College and Hospital.
Result:
Seventy-three male (73%) and twenty seven female patients (27%) with age range of 16 to 75 years were evaluated. Out of 100 patients 24% were in between 46-55 years age group. 75% of CLD were due to Hepatitis B, 7% due to Hepatitis C, 18% due to others. 32% patients have EV and 68% patients do not have EV.
Figure-1 shows that majority of CLD patients 63% fall in child Pugh class A group, followed by 32% fall in child Pugh class B & 5% fall in child Pugh class C. 
Discussion:
In this study all the patients were grouped in six age groups. Majority of the study subjects were in between 46-55 years age group 24% followed by 23% between 36-45 years age group. Ahsan T et al 10 found 28% in between 46-55 years age group which coincide with our study. 73% were male and 27% female. Male female ratio was 2.7:1. Mahtab et al 11 found malefemale ratio of 2.97:1, which almost coincide with our study. In this study 63% patient fall in child Pugh class A group, 32% fall in child Pugh class B & 5% fall in child Pugh class C .This study almost coincide with the study of khan H et al 4 Present study shows that 29 pt (29%) out of 100 have hypoalbuminaemia (<3.5gm/dl that is group A) while 71 pts (71%) had albumin level > 3.5gm/dl that is group B. In group A (Albumin level <3.5 gm/dl), 18 pts (62.06%) have EV, and 11 patient (37.93%) did not have EV. In group B (Albumin level >3.5 gm/dl), 14 pts (19.71%) have EV, and 57 patient (80.28%) did not have EV. Mean serum albumin level was 3.8 gm/ dl. Khan H et al. 4 found 57 pts (28.9%) out of 197 have hypoalbuminaemia (<3.5gm/dl). Among them 35 pts (61.4%) have EV, while 140 pts (71.1%) had albumin level >3.5gm/dl) with 28 having EV (20%). This consistent with the present study. From this study, hypoalbuminaemia (<3.5gm/dl) is 56% sensitive & 83.8% specific for presence of EV with positive predictive value of 62.06% & negative predictive value of 80.2% and odds ratio is 6.6 and P value is <0.001( Table 2 ) that is association between hypoalbuminaemia and Esophageal varices is significant. This study almost coincide with the study of khan H et al 4 which shows that hypoalbuminaemia (<3.5gm/dl) is 53.2% sensitive &91% specific predictor of EV with positive predictive value of 73.3% and negative predictive value of 80.8% and odds ratio of 11.57. Zein et al 14 in a study of 183 patients with primary sclerosing cholangitis, found 66% sensitivity, 80% specificity, 53.4% PPV, 87.2% NPV and odd ratio of 7.8 for albuminaemia of <3.5 gm%; almost similar to our results. The minor differences in figures could be explained on the basis of difference in etiology of the study population and sample size. khan H et al 4 used study population with uniform etiology of infective hepatitis & Zein et al 14 in a study of 183 patients with primary patients with CLD of diverse etiologies. The minor differences in sclerosing cholangitis, Bressler et al 15 found albuminemia of <4gm% as an independent risk factor for EV with odd ratio of 6.02 We used albuminemia of <3.5 gm% while Schepis et al 13 and Sarwar et al 16 used level of <2.95 gm% to predict the presence of EV. Odds ratio was 6.6 and the difference could be explained by <3.5 gm% albumin level we used and our study population with CLD with diverse etiology. Specificity of 83.8% and PPV of 62.06% suggests that hypoalbuminemia is a good indicator of EV. However, low sensitivity of hypoalbuminemia (56%) and NPV of 80.2% indicates that absence of hypoalbuminema does not rule out EV.
Conclusion:
Patients with chronic liver disease frequently undergo endoscopy of upper GIT to detect EV. Doing endoscopy in all patients of CLD will increase socio-economic and medical load because of the rising numbers of such patients. Therefore, there is a particular need for a noninvasive predictor for the presence of EV to ease the medical, social and economic burden of the disease. Many previous studies have documented good predictive value of various non-endoscopic variables for the presence or absence of varices, but available data in our country is limited. We consider simple, commonly available parameter serum albumin. From this study it is assumed that hypoalbuminaemia is a good non-endoscopic marker for the presence of esophageal varices.
